Join
Live feed
·
PRReleasevia Quantisnow
Hepion Pharmaceuticals Inc. logo

Hepion Pharmaceuticals Schedules Conference Call to Review Data from Phase 2a 'AMBITION' Clinical Trial of CRV431 in NASH

ByQuantisnow·Wall Street's wire, on your screen.
HEPA· Hepion Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HEPA (Hepion Pharmaceuticals Inc.) and more on Quantisnow.